Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET/MR and Biomarkers for Cardiopulmonary Dysfunction After Radiotherapy
NCT04901884Recruiting
- Sponsor
- University Health Network
- Start
- Jun 2021
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial of fludeoxyglucose f 18 in pulmonary hypertension (PH), sponsored by University Health Network. Primary endpoints: Change of FDG uptake of heart, Change of FDG uptake of lungs and 2 more. Started Jun 2021; status: recruiting.
02
Drugs
fludeoxyglucose f 18
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT04901884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04901884.